semaglutide patent date No Generics Approved in China One Month After Expiry Novo Nordisk Cuts Wegovy Prices

Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database

Access to treatment: affordable programmes for GLP-1 drugs where needed, combined with lifestyle support

It is to improve body composition in a way that supports long-term health

doi: 10.1038/nature23270

Understanding when bowel changes represent a normal medication effect versus a potentially serious complication is essential for patient safety

A systematic review from Australias Hunter Medical Research Institute found that although diabetes and obesity drugs are linked to substantial weight loss, clinical trials have largely failed to report what people are actually eating while taking them. A reduction in body weight does not automatically mean a person is well-nourished or healthy, said Clare Collins, laureate professor of nutrition and dietetics at The University of Newcastle, in a press release